Secondary Logo

Journal Logo

March 2001 - Volume 29 - Issue 3
pp: 473-702



Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients

Abraham, Edward; Laterre, Pierre-François; Garbino, Jorge; More

Critical Care Medicine. 29(3):503-510, March 2001.


Effects of a dual inhibitor of tumor necrosis factor-α and interleukin-1 on lipopolysaccharide-induced lung injury in rats: Involvement of the p38 mitogen-activated protein kinase pathway

Yoshinari, Daisuke; Takeyoshi, Izumi; Koibuchi, Yukio; More

Critical Care Medicine. 29(3):628-634, March 2001.









Show: